Management of the ‘wicked’ combination of heart failure and chronic kidney disease in the patient with diabetes
Bell DSH, McGill JB, Jerkins T
Diabetes Obes Metab. Pub. online 6 Jul 2023.
Leggi
Breaking news
Development and validation of a real‐world model to predict 1‐year Level 3 (severe) hypoglycaemia risk in adults with diabetes (the iNPHORM study, United States)
Ratzki-Leewing AA, Black JE, Ryan BL, et al.
Diabetes Obes Metab. Pub. online 6 Jul 2023.
Leggi
An update on the incidence of type 1 diabetes during the COVID-19 pandemic years
Giorda CB, Gnavi R, Tartaglino B, et al.
Diabetes Obes Metab. Pub. online 3 Jul 2023.
Leggi
Safety of sodium‐glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
Rigato M, Fadini GP, Avogaro A
Diabetes Obes Metab. Pub. online 4 Jul 2023.
Leggi
All‐cause mortality and cardiovascular outcomes with sodium‐glucose Co‐transporter 2 inhibitors, glucagon‐like peptide‐1 receptor agonists and with combination therapy in people with type 2 diabetes
Riley DR, Essa H, Austin P, et al.
Diabetes Obes Metab. Pub. online 29 Jun 2023.
Leggi
Diabetic foot ulcers: a review
Armstrong DG, Tan TW, Boulton AJM, et al.
JAMA. 2023;330(1):62-75.
Leggi
Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a modelling study
Fan M, Stephan AJ, Emmert-Fees K, et al.
Diabetologia. Pub. online 30 Jun 2023.
Leggi
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the CREDENCE trial
Doi Y, Hamano T, Yamaguchi S, et al.
Diabetes Obes Metab. Pub. online 29 Jun 2023.
Leggi
A comparison of faster insulin aspart to standard insulin aspart using hybrid automated insulin delivery system in active children and adolescents with type 1 diabetes: a randomized, double-blind crossover trial
Dovc K, Bergford S, Fröhlich-Reiterer E, et al.
Diabetes Technol Ther. Pub. online 5 Jul 2023.
Leggi
Diabetes remission in drug‐naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort study
Zeng J, Gan S, Mi N, et al.
Diabetes Obes Metab. Pub. online 29 Jun 2023.
Leggi